LSE:DEST (Destiny Pharma Plc)

About DEST

Destiny Pharma Plc engages in the discovery, development and commercialization of new antimicrobial products. Its products include XF drug series, XF-73 and Pipeline. The company was founded by Suzanne Brewer, Kevin Brewer and William Guy Love on March 4, 1996 and is headquartered in Brighton, the United Kingdom.
  • Should you invest £1,000 in Destiny Pharma Plc right now?

    When investing expert Mark Rogers has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets.

    And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if Destiny Pharma Plc made the list?

    See the 6 stocks